These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9236550)
1. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Glantz LA; Lewis DA Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550 [TBL] [Abstract][Full Text] [Related]
2. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Glantz LA; Lewis DA Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775 [TBL] [Abstract][Full Text] [Related]
3. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207 [TBL] [Abstract][Full Text] [Related]
4. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Glantz LA; Austin MC; Lewis DA Biol Psychiatry; 2000 Sep; 48(5):389-97. PubMed ID: 10978722 [TBL] [Abstract][Full Text] [Related]
5. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Akil M; Pierri JN; Whitehead RE; Edgar CL; Mohila C; Sampson AR; Lewis DA Am J Psychiatry; 1999 Oct; 156(10):1580-9. PubMed ID: 10518170 [TBL] [Abstract][Full Text] [Related]
7. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Pierri JN; Chaudry AS; Woo TU; Lewis DA Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733 [TBL] [Abstract][Full Text] [Related]
8. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia. Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236 [TBL] [Abstract][Full Text] [Related]
9. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Glantz LA; Lewis DA Arch Gen Psychiatry; 2000 Jan; 57(1):65-73. PubMed ID: 10632234 [TBL] [Abstract][Full Text] [Related]
10. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007 [TBL] [Abstract][Full Text] [Related]
11. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Glantz LA; Gilmore JH; Hamer RM; Lieberman JA; Jarskog LF Neuroscience; 2007 Nov; 149(3):582-91. PubMed ID: 17916412 [TBL] [Abstract][Full Text] [Related]
12. Selective reduction of chromogranin A-like immunoreactivities in the prefrontal cortex of schizophrenic subjects: a postmortem study. Iwazaki T; Shibata I; Niwa S; Matsumoto I Neurosci Lett; 2004 Sep; 367(3):293-7. PubMed ID: 15337252 [TBL] [Abstract][Full Text] [Related]
13. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Young CE; Arima K; Xie J; Hu L; Beach TG; Falkai P; Honer WG Cereb Cortex; 1998; 8(3):261-8. PubMed ID: 9617921 [TBL] [Abstract][Full Text] [Related]
14. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Hashimoto T; Bazmi HH; Mirnics K; Wu Q; Sampson AR; Lewis DA Am J Psychiatry; 2008 Apr; 165(4):479-89. PubMed ID: 18281411 [TBL] [Abstract][Full Text] [Related]
15. Elevated synaptophysin I in the prefrontal cortex of human chronic alcoholics. Henriksson R; Kuzmin A; Okvist A; Harper C; Sheedy D; Garrick T; Yakovleva T; Bakalkin G Synapse; 2008 Nov; 62(11):829-33. PubMed ID: 18720419 [TBL] [Abstract][Full Text] [Related]
16. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects. Crook JM; Akil M; Law BC; Hyde TM; Kleinman JE Mol Psychiatry; 2002; 7(2):157-64. PubMed ID: 11840308 [TBL] [Abstract][Full Text] [Related]
18. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex. Broadbelt K; Jones LB J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558 [TBL] [Abstract][Full Text] [Related]
19. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Eastwood SL; Burnet PW; Harrison PJ Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874 [TBL] [Abstract][Full Text] [Related]
20. Synaptophysin immunohistochemistry reveals inside-out pattern of early synaptogenesis in ferret cerebral cortex. Voigt T; De Lima AD; Beckmann M J Comp Neurol; 1993 Apr; 330(1):48-64. PubMed ID: 8468403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]